Coeliac Disease Clinical Trials Coeliac Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Condition:   Celiac Disease Interventions:   Drug: Ritlecitinib;   Drug: Placebo;   Other: Gluten Sponsors:   Massachusetts General Hospital;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials